Elutia (ELUT) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

ELUT Elutia

Watchlist

4.340
+0.200+4.83%

Close Dec 2 16:00 ET

150.00MMarket Cap-2170P/E (TTM)

Pre-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Elutia Awarded Cardiac Rhythm Management Devices Agreement With Premier, Inc.
GlobeNewswireDec 2 08:00 ET
Elutia Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Yahoo FinanceNov 17 07:31 ET
Express News | Cantor Fitzgerald Reiterates Overweight on Elutia, Maintains $10 Price Target
BenzingaNov 15 09:46 ET
Elutia Analyst Ratings
BenzingaNov 15 09:44 ET · Ratings
Elutia Inc. Reports Strong Q3 Results, Prepares for Major Product Launch
TipRanksNov 14 23:13 ET
Elutia Inc. (ELUT) Q3 2024 Earnings Call Transcript Summary
moomoo AINov 14 20:15 ET · Conference Call

Comments

Rafey Jan

Sep 5 16:09

$Elutia (ELUT.US)$
@Team moomoo
Why is there a halt in trading?

Jaguar8

Sep 5 15:32

Hey you! Why aren’t you open?🤣

$Elutia (ELUT.US)$

Jaguar8

Sep 5 15:05

NEWS

$Elutia (ELUT.US)$
Elutia Announces First Patient Implant of EluPro™, the World’s First Drug-Eluting BioEnvelope for Cardiac Pacemakers and Neurostimulators
Elutia Inc. (Nasdaq: ELUT) has announced the first patient implant of EluPro™, the world's first FDA-cleared antibiotic-eluting biologic envelope for cardiac pacemakers and neurostimulators.
The procedure was performed by Dr. John Catanzaro at East Carolina University Health Medical Center. EluPro is designed to prevent post-operative co...